Home > Financial Ratios > ALEMBIC PHARMACEUTICALS

ALEMBIC PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
ALEMBIC PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
AD     Remove this Ad

ALEMBIC PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 9.2735.24-23.09-41.0227.66

What is the latest Core EBITDA Growth ratio of ALEMBIC PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of ALEMBIC PHARMACEUTICALS is 9.27 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar20259.27
Mar202435.24
Mar2023-23.09
Mar2022-41.02
Mar202127.66

How is Core EBITDA Growth of ALEMBIC PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 9.27
-73.69
Mar2024 35.24
Positive
Mar2023 -23.09
Negative
Mar2022 -41.02
Negative
Mar2021 27.66 -

Other Financial Ratios of ALEMBIC PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of ALEMBIC PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ALEMBIC PHARMACEUTICALS ₹15,154.9 Cr -0.7% 1.1% -6.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹415,613.0 Cr 0.9% 6.2% 0.6% Stock Analytics
DIVIS LABORATORIES ₹167,105.0 Cr 1.8% 4.8% 6.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,926.0 Cr 1.3% 9.8% 37.7% Stock Analytics
DR REDDYS LABORATORIES ₹109,088.0 Cr 1.7% 5.8% 6.7% Stock Analytics
CIPLA ₹107,120.0 Cr -1.3% 0.9% -8.9% Stock Analytics


ALEMBIC PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ALEMBIC PHARMACEUTICALS

-0.7%

1.1%

-6.3%

SENSEX

0%

1.2%

9.7%


You may also like the below Video Courses